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Abstract: Proteasomes are key proteases involved in a variety of processes ranging from 
the clearance of damaged proteins to the presentation of antigens to CD8+ T-lymphocytes. 
Which cleavage sites are used within the target proteins and how fast these proteins are 
degraded have a profound impact on immune system function and many cellular metabolic 
processes. The regulation of proteasome activity involves different mechanisms, such as 
the substitution of the catalytic subunits, the binding of regulatory complexes to proteasome 
gates and the proteasome conformational modifications triggered by the target protein itself. 
Mathematical models are invaluable in the analysis; and potentially allow us to predict the 
complex interactions of proteasome regulatory mechanisms and the final outcomes of the 
protein degradation rate and MHC class I epitope generation. The pioneering attempts that 
have been made to mathematically model proteasome activity, cleavage preference variation 
and their modification by one of the regulatory mechanisms are reviewed here. 
Keywords: proteasome; mathematical model; 11S; 19S; non-catalytic modifier sites 
 
OPEN ACCESS
Biomolecules 2014, 4 586 
 
 
1. Introduction 
The ubiquitin-proteasome system (UPS) is a complex system responsible for the degradation of the 
majority of the cytoplasmic proteins. It is formed by a group of E1-E2-E3-E4 enzymes that tag target 
proteins with poly-ubiquitin chains, carry them into the proximity of proteasomes, where they are 
broken into small peptides [1,2]. Although polyubiquitination is determining the selection of the target 
proteins, various proteasome isoforms exist, which have degradation rates that vary from protein to 
protein [3,4], thus suggesting mechanisms within the proteasome per se ipse that regulate the protein 
degradation rates. The regulation of proteasome activity has a profound impact on cellular metabolic 
pathways (e.g., chromatin activation, transcription factor activation, RNA processing and ribosome 
biogenesis, aberrant polypeptide degradation, cell cycle and differentiation), on inflammation (e.g., 
cytokine production and signalling) and on the immune system (e.g., thymocyte selection and maturation, 
lymphocyte activation) [3,5]. 
The 20S proteasome, which is the central proteolytic machinery of the UPS, is composed of  
four stacked seven-membered rings (7777). The catalytic chamber comprises six catalytic subunits 
(two 1, 2 and 5 subunits) that carry out peptide-bond hydrolysis and peptide splicing [6–8]. 
Polypeptide substrates bind with the residues that are located at the N-terminal and the C-terminal 
sides of the cleaved residue to the non-primed and primed substrate-binding sites of the proteolytic 
pocket, respectively. Such binding provides the stability and the orientation of the substrate, thereby 
allowing the peptide-bond hydrolysis by the N-terminal Thr of the catalytic subunits [9]. In mammals, 
there exist different variants of the catalytic  subunits. Differential usage of these variants represents 
one example of proteasome activity regulation. For instance, following inflammatory stimuli, such as 
IFN-, the catalytic standard 1, 2 and 5 subunits peculiar to the standard proteasome are replaced 
by the immuno-subunits, 1i, 2i and 5i, in the newly synthesized immunoproteasome. The latter  
can carry out a variety of functions in the regulation of cellular homeostasis, cell cycle and other 
metabolic processes, as well as major histocompatibility complex (MHC) class I-mediated antigen 
presentation [3,10]. Differences in the peptide-bond cleavage preferences of standard and immune 
proteasomes and the implications for MHC class I epitope production have been investigated in 
considerable detail. Recently, we were able to demonstrate that the catalytic-subunit substitution leads 
to only quantitative effects and, thus, does not result in different peptide repertoires generated by 
standard- and immuno-proteasomes [4]. The specific activity of immunoproteasomes or its alteration 
has been linked to a variety of pathologies, such as neurodegenerative and autoimmune diseases [11–14]. 
A second way to regulate proteasome activity is given by the binding of regulatory complexes,  
such as 11S and 19S complexes, to the proteasome -rings. This facilitates the peptide channelling by 
gate opening, thereby controlling both substrate entry and product release [15,16]. Binding of 11S and 
19S complexes also induces conformational changes of the proteasome that affect the substrate binding 
sites and alter its cleavage preferences [17–22]. NMR spectroscopy has provided evidence that binding 
of the 11S complex to the -subunits of the archaebacterium 20S proteasome triggers a wave of 
allosteric modifications across a network of contiguous structural regions, which reaches the  subunit 
(the S3 substrate-binding pocket) [21]. 
A third mechanism of proteasome activity regulation consists of conformational changes induced 
by substrate binding, creating a type of positive/negative feedback loop. It has been shown that 20S 
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proteasomes interconvert between multiple conformations, whose relative populations are shifted upon 
peptide-bond hydrolysis. Indeed, the engagement of the catalytic Thr1- amine of each active  subunit 
by peptide substrates is coupled to gate opening, thus resulting in a generalized positive feedback loop, 
leading to proteolysis [23]. In addition, peptide substrates have been shown to regulate proteasome 
activity by binding non-catalytic regulatory sites, although their location remains unknown [24–26]. 
Binding of fluorogenic peptides Suc-LLVY-mna and Suc-FLF-mna to non-catalytic regulatory sites 
leads to 20S proteasome gate opening and an increase of the cleavage rate by all three catalytic  subunits. 
Because the allosteric modification acts on the proteasome gate, the presence of other gate-related 
regulatory complexes with stronger effects (such as 11S) cover the effect of these non-catalytic 
modifier sites [26]. In contrast, the peptide substrate, Z-LLE-na, binds other non-catalytic regulatory sites, 
thereby inhibiting the activity of the 5 subunit. Such a substrate also enhances the Boc-LLR-mca 
degradation (mainly catalysed by 2 subunit) by binding the 1 subunit catalytic site. The latter two 
regulatory mechanisms are even more pronounced in the presence of 11S or 19S complexes [25].  
This suggests that specific substrate peptides can regulate proteasome peptide-bond hydrolysis by 
trigging conformational modifications of the  rings, also independently, to an action towards gate 
opening. Regulatory effects have been also described by poly-ubiquitinated protein substrates on  
the 26S proteasome (formed by the 20S proteasome and 19S complex). Indeed, binding of  
the polyubiquitinated substrate, Ub5-MUC4, to the 19S complex leads to an increased degradation of 
short fluorogenic peptides by the 26S proteasome [27]. It has been proposed that binding of the  
poly-ubiquitinated substrate to the 19S regulator in conjunction with an ATP-consuming process induces 
a stabilization of the interaction between the 19S complex and proteasome  subunits and facilitates 
the access to the catalytic sites, thereby enhancing the proteolytic rate of the proteasome core [27]. 
2. The Importance of Modelling to Understand Molecular Mechanisms 
The molecular mechanisms underlying cellular functions are typically depicted in terms of diagrams, 
laws, graphs, plots, relationships, chemical formulae, reaction schemes (pathways), biomolecular 
reactions, etc. Such representations form the starting point for the development of mathematical 
models (Figure 1). The advantage of a mathematical model is that it forces us to state our assumptions 
explicitly. Following this, it becomes then possible to test our understanding by either solving or 
simulating the resulting sets of equations. In practice, most biological systems of real-world relevance 
and interest are too complex to be solved exactly, and computer simulations are required to make 
predictions. These predictions reflect our assumptions about the mechanisms, and by comparing 
simulations with experimental data, we are able, at least in principle, to test our understanding.  
The main difference to verbal models (for example, of the type “molecule X does this when Y is 
present, which leads to the increase in Z”) is that the predictions are quantitative and unambiguous: 
there is little room for a lack of precision once a mathematical model has been invoked. 
In practice, however, developing a model is only a small step. A very important, but also tedious, 
part of model development is the estimation of reliable values for the numerous parameters (reactions 
rates, binding constants, half-life of molecular complexes) entering the equations that form the model. 
However, before we can make predictions, we have to know these parameters. Obtaining this from of 
data is itself a challenge, and arguably, once these parameters are known with any degree of certainty 
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(in the statistical sense), further analysis becomes very straightforward indeed. The increasing 
availability of quantitative data in cell and molecular biology has been one of the driving factors in 
much recent statistical research, as it has been notoriously difficult to obtain reliable parameter 
estimates for the mathematical models of biological systems. Recent research has shown that this need 
not be a problem, as long as the confidence intervals of the parameters can be evaluated [28]. In the 
case that a parameter cannot be inferred from experimental data, it is likely that the system is not 
sensitive to this parameter or that the data are not informative enough. In most cases, however, it is 
possible to determine parameter distributions (ranges over a parameter) that can be sufficient enough 
to distinguish between alternative mechanisms. 
Figure 1. Mathematical modelling in molecular biology. Mathematical models of biological 
systems have to engage with experiments. Modelling prompts further experiments, and 
experiments allow us to parameterize and improve our models or choose from different models 
or mechanistic hypotheses using statistical analysis. Modelling has furthermore become  
an essential aspect of experimental design: not all data are informative, and investigating 
alternative experimental approaches in silico allows us to design more informative, more 
discriminatory experimental set-ups that result ultimately in better models. 
 
Once we have encoded our mechanistic assumptions into mathematical models, we can also:  
(i) compare and rank different models in light of the available data [29–33]; and (ii) hone the 
experimental setup in light of simulations of the model(s) [34–36]. This, in turn, enables us to improve 
the models and our understanding in an iterative manner. 
3. Mathematical Models to Describe the Proteasome Hydrolysis of Short Fluorogenic Peptides 
In order to understand the mechanisms of proteasome regulators, one has to understand the details 
of proteasome hydrolysis of peptides per se. One way to achieve this is by mathematically modelling the 
degradation rate of short fluorogenic peptides. Such peptides bind only the non-primed substrate-binding 
site of the proteasome. Although they are preferentially cleaved by one of the active sites, they do not 
mirror the cleavage preferences for peptide-bonds embedded within a polypeptide sequence [4], and 
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thus, in the text, we avoid correlating their degradation to the so-called chymotrypsin-like, trypsin-like 
and caspase-like activities. Nevertheless, the usage of these substrates allowed the investigation of  
a simplified version of the complex proteolytic process of long polypeptides and, thus, the development 
of pioneering mathematical models of proteasome activity and regulation. 
An ideal mathematical model of proteasomal peptide cleavage should contain a description of the 
separate following biophysical and biochemical steps (Figure 2):  
• the substrate uptake into the proteasome chamber 
• the substrate translocation inside the proteasome chamber 
• binding of the substrate to the active site 
• hydrolysis of the peptide bond on the active site 
• release of the products out of the proteasome chamber 
Figure 2. Elementary steps along the reaction path, which may determine the degradation 
kinetics of a small fluorogenic peptide. (1) Uptake and release of the peptide through the 
openings (gating); (2) binding of the peptide to non-catalytic modifier sites; (3) generation 
of the chromophore with a different efficiency at different active sites. 
 
Furthermore, a formulation describing the influence and mechanisms of proteasome regulators 
should be included. However, due to the lack of suitably detailed experimental data and due to the 
complexity of this system, the modelling approaches so far had to focus on specific aspects of the 
entire hydrolysis process. In the following, we will present an overview of published models and 
highlight their underlying hypotheses and main findings. 
The first paper by Stein et al. [37] investigated the hydrolysis of the short fluorogenic peptide,  
Suc-LLVY-mca, over time and its dependency on the initial substrate concentration. They found that the 
hydrolysis of Suc-LLVY-mca by the rabbit muscle 20S proteasome exhibits two phases: an initially 
rapid degradation rate is followed by slower degradation setting in long before substrate depletion.  
The authors modelled these biphasic processes through enzyme hysteresis. They observed an inverse 
proportionality between the hysteresis rate and the substrate concentration. Furthermore, the authors 
detected a decrease of the hydrolysis rate in both initial and final phases with increasing substrate 
concentration, which they modelled as substrate inhibition [37]. The reaction scheme is shown in 
Figure 3A. 
In 2000, Schmidtke et al. [24] used mathematical modelling in order to describe the hydrolysis rate 
of all three active sites under the influence of an effector (i.e., Ritonavir). They found evidence for  
a non-catalytic modifier site, which upregulates the cleavage of the Bz-VGR-mca substrate,  
but downregulates the Suc-LLVY-mca degradation. The authors developed a two-site-modifier model, 
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which they calibrated against time series data (mouse liver 20S proteasome) using a set of combinations 
of substrate and effector concentration. Based on the reaction scheme, the authors derived a so-called 
velocity equation, which describes the rate of substrate degradation at steady state. The reaction 
scheme and the resulting velocity equation of the two-site-modifier model is shown in Figure 3B.  
This kinetic model was applied to experimentally measure degradation rates of the short fluorogenic 
peptides, Suc-LLVY-mca, Bz-VGR-mca, Z-GGL-mca and Z-LLE-mca, under varying concentrations 
of the effector protein, Ritonavir. Based on the estimated model parameter, it was concluded that 
Ritonavir influences the hydrolysis of Suc-LLVY-mca, Bz-VGR-mca and Z-GGL-mca by binding to  
a non-catalytic regulator site. Ritonavir furthermore competes with Suc-LLVY-mca, Z-LLE-NA and 
Z-GGL-mca, but not Bz-VGR-mca, for binding at the active site. The two effects together led to  
an enhanced hydrolysis of Bz-VGR-mca and an inhibited hydrolysis of Suc-LLVY-mca. Furthermore, 
the authors found strong self-inhibition of Suc-LLVY-mca, which could be explained by cooperative 
binding kinetics. 
Figure 3. Model reaction schemes for hydrolysis of short-fluorogenic peptides. Shown are 
the kinetic reaction schemes to describe specific aspects of proteasome peptide hydrolysis 
as proposed by (A) Stein et al. [37], (B) Schmidtke et al. [24] and (C) Stohwasser et al. [15]. 
E denotes the proteasome (enzyme) to which a substrate, S, can bind and create a  
substrate-enzyme complex. A dot (.) denotes a free binding site; P denotes the resulting 
product. (A) The hysteresis model allows the transition from the standard form, E, to  
a modified form with a different kinetic parameter, E’. (B) The two-site modifier model 
allows for binding of a modifier molecule, I, to both binding sites, which results in 
changing the kinetic parameter of E. In (A) and (B), the arrows for substrate input are not 
shown to avoid complexity. (C) The 11S activator model describes the cooperative binding 
of n substrate molecules to the latent proteasome, E, which results in an activated 
proteasome, Eact. However, further cooperative binding of m substrate molecules results in 
an inactive proteasome, Einact. 
 
Later in the same year, Stohwasser et al. [15] investigated the influence of the proteasome activator, 
11S, on the hydrolysis rate of the substrates, Suc-LLVY-mca, Bz-VGR-mca and Z-LLE-mca, by latent 
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20S proteasomes (purified from mouse liver and B8 fibroblasts) also using a kinetic model. In this 
model, the proteasome can exist in three states: latent proteasome, active proteasome and inhibited 
proteasome. Cooperative binding of substrate molecules activates the latent proteasome. However,  
if the substrate concentration reaches a critical threshold, the active proteasome will be inhibited.  
This reaction scheme (Figure 3C) was calibrated against experiments in the presence and absence of 
the 11S complex in order to determine the kinetic parameters that were altered. The main conclusion 
was that in the presence of the 11S complex, the substrate affinity to the activating site was enhanced, 
whereas the affinity to the inhibiting site was decreased. However, the maximum activities remained 
the same. These findings were consistent, independent of the substrate used. It appears that the 
substrate uptake and release by the proteasome are the rate limiting steps of peptide hydrolysis. The 
presence of the 11S complex facilitates the peptide uptake and release through the proteasome gates, 
which therefore results in an enhanced peptide hydrolysis. 
The three different kinetic models mentioned above have in common that they treated the 
proteasome as a peptide-cleaving enzyme, which can be analysed by methods traditionally applied  
in single-enzyme kinetics. However, such an approach ignored the fact that the proteasome represents 
a whole kinetic system, which encompasses several spatial transport steps, as well as a combination of 
different enzymatic activities. Thus, quantifying the rate with which a model substrate is cleaved by 
the proteasome by measuring the appearance of cleavable products in the external space integrates 
across the contribution of different kinetic processes. With currently available experimental techniques, 
these processes cannot be individually dissected. 
4. Modelling the Proteasomal Hydrolysis of Oligo- and Poly-Peptides 
Whereas the models described above focus on the kinetic parameter of the active sites and potential 
regulatory sites, a second class of models focuses on the length distribution of generated fragments 
from oligo- or poly-peptides. Since the latter scenario is more complex and the basic kinetic characteristics 
of the proteasome are still not well defined, these models tended to contain a phenomenological 
description of the peptide hydrolysis. Furthermore, for reasons of simplicity, more or less strong 
assumptions needed to be made in order to describe such a system. As we will show, some of these 
assumptions were later on disproven by experimental studies, thereby demanding the development of 
new updated mathematical models. 
The first attempt to mathematically model the pattern of proteolytic fragments generated by 20S 
proteasomes from oligopeptides was in 2000 by Holzhütter and Kloetzel [38]. Kinetic equations were 
derived that described the time course of the average cleavage probabilities of peptide fragments based 
on a given substrate sequence. The first assumption was that only a single substrate could enter the 
proteasome chamber. A second substrate could only enter once the first substrate was fully processed 
and all resulting fragments were released. However, this assumption has to be considered with care. 
Indeed, plasmon-resonance studies of Hutschenreiter et al. [39] revealed that the proteasome can bind 
two substrate molecules in a positive-cooperative manner. From this observation, the authors concluded 
that substrate cleavage might take place simultaneously in both half-proteasomes. Moreover,  
cryo-microscopic studies of Sharon et al. [33] suggested that all cavities of the 20S proteasome can 
simultaneously harbour bulky substrates, like green fluorescent protein or Cytochrome C. Furthermore, 
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by investigating proteasomal peptide splicing, two groups showed that the proteasome can ligate 
together two peptides derived from different molecules, thereby demonstrating that a second substrate 
molecule can access proteasome cavity when the degradation products of the first molecule are still 
inside the cavity [8,40]. With the proposed stop-and-go process, Holzhütter and Kloetzel [38] also 
avoided having to include binding competition effects into their model. Furthermore, it was assumed 
that the affinity of a substrate only depends on the P1 residue for the first cleavage rather than the P1’ 
and surrounding residues. Finally, due to a lack of experimental evidence of substrate translocation rates, 
an exponential decay for the size dependency for the rate by which fragments are released was chosen. 
Despite all these assumptions, after calibrating the model to experimental data, the authors found  
that fragments generated by two cleavages had an average length of 7–13 amino acids and that their  
C-terminus was cleaved first, followed by the cleavage at the N-terminus. Overall, it was shown that 
only 10% of all possible cleavage site combinations (combinations of amino acid positions in a given 
substrate) were actually used to generate double-cleavage fragments. This is due to differences in  
the cleavage rates of the P1 residues, as well as due to the accessibility of the N- and C-fragment of  
the substrate in order to form a peptide bond. 
In 2002, Peters et al. [41] formulated a kinetic model that describes the time evolution of fragment 
formation based on in vitro digestions of polypeptides by 20S proteasomes purified from human T2 
and T2.27 cell lines. The model summarized all details involved in peptide hydrolysis as a single step, 
which was described by the overall observed procession rate. The procession rate includes all events 
from peptide uptake up to the release of the generated products of that peptide and is comparable to the 
peptide turnover. The model could be seen as a Michaelis–Menten-type model with phenomenological 
parameters. In this study, it was assumed that the peptide degradation rate was monotonously increased 
with increasing peptide length. For long polypeptides and entire proteins, this assumption did not hold, 
which limited the model to oligopeptide studies. Furthermore, a cleavage probability had to be a priori 
assigned to each peptide bond in the substrate. It was assumed that all cleavages occurred independently 
of one another. The authors developed the “mass-balance method”, which is based on the principle  
that the number of molecules in a reaction system is preserved. The method was used to calibrate the 
kinetic model against mass-spectrometry data. This study was able to simulate the time course of 
peptide fragments that was in good correspondence with the experimentally determined time course of 
fragment abundance. 
A set of cleavage probabilities for a given substrate and the length of the substrate characterized  
the latter two mathematical models [38,41]. In 2005, Luciani et al. [42] proposed a model, which built 
upon those two studies. Here, the model was fully characterized by the length of the substrate [42]. 
The main assumptions of the previous studies, however, remained comparable, which was the  
decrease of the peptide release rate with increasing peptide length and a preferential production of 
fragments with a length of approximately nine amino acids. The peptide degradation is described by  
a Michaelis–Menten-type model, where the maximum reaction rate (vmax) is inversely proportional  
to the peptide length. As a result, the model describes the length distribution of generated fragments 
over time. Interestingly, this study investigated the effect of gate opening on the length distribution by 
using data obtained with open-channel mutant proteasomes [16]. It was shown that opening of the gate 
resulted in an increase of long fragments and a decrease of shorter fragments, due to the increased rate 
of influx and efflux. 
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In 2008, Mishto et al. [43] proposed a further development of the latter mathematical model.  
This contains more details on the substrate-peptide uptake and release by the proteasome, which again 
was dependent on the length of the substrate-peptide. In addition to the peptide length, the authors 
introduced the substrate site-specific cleavage strength to describe the frequency of the substrate 
cleavage-site usage based on experimental data measured by mass spectrometry (using the 20S 
proteasome from the lymphoblastoid cell line, LcL). The model was calibrated against in vitro 
digestions of several polypeptide substrates. Another focus of this study was the effect of the 
proteasome regulator 11S complex on the time course of the hydrolysis products. The model outcomes 
suggested that the 11S complex increases the peptide uptake by the proteasome and allows a wider 
range of peptide lengths to be transported. 
Several biophysical models have been proposed that describe the length distribution of peptide 
fragments. In these models, the active influx of peptide molecules into the proteasome chamber [44], 
as well as the translocation characteristics of peptides [45] were taken into account. A stochastic model 
to quantify the fragment patterns of polypeptide hydrolysis was developed later on by Goldobin et al. [46]. 
This model aimed at describing the protein translocation and cleavage, taking into account the 
topology and, thus, the reciprocal distance of the cleavage centres. The main steps modelled were the 
substrate translocation, substrate cleavage and product fragments removal. Substrate translocation was 
described as a sequence of residue-by-residue jumps induced by thermal noise. Jumps were allowed to 
occur only in the forward direction. The probability of a jump is assumed to depend on the length of 
the substrate. The translocation rate, therefore, only depends on the substrate length. By contrast,  
the cleavage of peptide bonds is described by residue-specific cleavage probabilities. The proteolytic 
fragments are assumed to be much more mobile than the substrate and, therefore, abandoned the 
proteasome chamber immediately after production. Any re-entry or competition effects were neglected. 
Taken together, all published models dealing with the processing of oligopeptides need as input  
a priori information on strong and weak cleavage sites and the length distribution of fragments to 
come up with correct simulations of a limited set of in vitro digests. 
5. Conclusions 
The modelling approaches considered in this review aimed at elucidating specific aspects of the 
regulatory mechanisms controlling the rate and specificity of proteasomal peptide hydrolysis (Table 1). 
Based on kinetic modelling, it was suggested that the proteasome is a hysteretic enzyme complex [37], 
which undergoes substrate inhibition [15,24,37]. The (protein or peptide) substrate can also act as  
an activator by cooperative binding events [15,24]. This model-based prediction was later confirmed 
by the experimental studies of Kisselev et al. [25,26]. The length of the substrate was shown to impact 
the substrate uptake and translocation [38,44,46]. In addition to the regulatory effects exerted by  
the substrate itself, the mechanisms of further regulators were described. Indeed, Ritonavir was shown 
to enhance the hydrolysis by binding to a regulatory site and competitively inhibiting the hydrolysis  
by binding to the active site [24]. Mathematical modelling also allowed elucidation of the regulatory 
function of 11S in that this complex enhances the overall proteolytic activity without affecting the 
maximum activities. 
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Table 1. Overview of published mathematical models of proteasome peptide hydrolysis. 
Type Year Author Summary 
short-fluorogenic 
peptide models 
1996 Stein et al. [37] 
proteasome model of enzyme hysteresis and  
substrate inhibition 
2000 Schmidtke et al. [24] 
two-site modifier model of proteasome hydrolysis  
in the presence of effectors (Ritonavir) 
2000 Stohwasser et al. [15] 
kinetic model of the effect of the activator 11S on 
proteasome hydrolysis 
oligo- and poly-
peptide models 
2000 Holzhutter et al. [38] 
time course of cleavage probabilities based on  
substrate sequence 
2002 Peters et al. [41] 
time course of cleavage fragments based on  
substrate sequence 
2005 Luciani et al. [42] 
time course of the fragment length distribution  
based on substrate length 
2008 Mishto et al. [43] 
time course of the fragment length distribution based on 
substrate length and substrate-specific cleavage strength 
under the influence of the 11S activator 
biophysical 
models 
2006 Zaikin et al. [44] 
biophysical model of the active influx of peptide 
molecules into the proteasome chamber 
2006 Zaikin et al. [45] biophysical model of peptide translocation characteristics 
2009 Goldobin et al. [46] stochastic model of protein translocation and cleavage 
There are, however, some issues that should be taken into account before developing new 
mathematical models of proteasome and proteasome regulatory processes. For instance, short fluorogenic 
peptides can help us to gain an understanding of the detailed biochemical reactions inside the 
proteasome chamber. However, the information on the mechanism of proteasomal cleavage of peptide 
bonds obtained from kinetic studies with such small fluorogenic peptides is limited by the fact that 
several elementary processes with different kinetic features may contribute to the observed changes  
in the fluorescent intensity of the used chromophore (Figure 2). First, it remains unclear how the 
transport of peptides, and even smaller peptide-based compounds, such as the short fluorogenic substrates, 
between the external space and the interior of the proteasome influences the overall kinetics of 
substrate degradation. It is possible that the entry and release of peptides through the openings in the  
-rings proceeds as a pure diffusion processes without significant interactions between the peptide and 
those amino acid residues shaping the surface of the openings. It cannot be excluded, however,  
that passage of the peptide through the openings involves one or even several distinct binding steps 
(peptide hopping) and that the affinity constants of these binding steps influence the measured overall 
proteasome affinity towards the peptide. Second, the experimental and mathematical studies [24–26] 
suggest the presence of non-catalytic binding sites, which, upon occupation by the peptide substrate, 
may alter the conformation of the proteasome and, thus, the kinetic properties of the catalytic sites. 
Third, none of the small reporter peptides in use are specific for one of the three different catalytic 
activities of the proteasome. Rather, it appears very likely that different active sites bind and cleave the 
small fluorogenic peptide with different efficiency [4], thus producing a complicated kinetics representing 
the superposition of the kinetics of each participating active site. At last, short fluorogenic peptides 
might have a weak unspecific binding to the inner or outer surface of the proteasome, leading to  
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a depletion of the substrate available for degradation. The alteration of measured fluorescence can also 
derive from the use of different plate readers [47]. 
To overcome some of these limitations, it is crucial in our opinion to consider oligo- and poly-peptide 
studies. However, even for the 20S core proteasome, a mathematical model that can reliably reproduce 
the main proteolytic fragments generated from an arbitrary oligo-peptide or even full-length protein 
substrate does not exist so far. The main problem hampering the development of such a model is  
the lack of experimental information on the spatio-temporal processes that the peptide substrate 
undergoes inside the proteasome chambers. The application of fluorescence resonance energy for  
the determination of the approach of the peptide substrate to distinct sites within the proteasome 
chambers could help to reconstruct the reaction path in space and time [48]. In addition, the development 
of new algorithms for the absolute quantification of peptides, produced by in vitro digestion of 
polypeptides, using mass spectrometry may allow one to review previous results and to improve  
the kinetic models [4,8]. 
From a methodological point of view, there is a need to better validate proposed models 
experimentally, as well as computationally. It would also be helpful to perform a model comparison to 
test alternative hypothesis. Furthermore, in the discussed studies, the models are based on data using 
different proteasome types (mouse, human, cell lines), which might lead to contradictory mechanisms 
and conclusions. 
In summary, even though the influence of regulatory mechanisms (e.g., 19S, 11S, non-catalytic 
modifier sites) can be directly concluded from experimental data, only kinetic modelling can push our 
knowledge with a deeper insight into the cause of the observed effects. Although the mathematical 
models published so far helped the scientific community to research proteasome function, several 
break-through studies recently improved the knowledge of the catalytic and regulatory processes of 
proteasome isoforms [9,21,23,49–51]. The time might be ripe for the development of new types of 
mathematical models, aiming at describing proteasome activities and regulations in toto.  
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